Global Opioid Use Disorder Market Research Report - Segmented By Drug (Buprenorphine [Sublocade, Belbuca, Suboxone, Zubsolv], Methadone, Naltrexone), By Route of Administration (Intravenous, Oral), By Age (19 to 40, 41 to 60, and 61 & over), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Opioid Use Disorder Market Size (2024 –2030)
The Global Opioid Use Disorder Market was valued at USD 3.21 billion and is projected to reach a market size of USD 6.54 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 10.7%.
Opioids are painkillers, but they can cause addiction and major health problems as well. The global challenge of treating opioid addiction is increasing due to the number of people who are battling opioid dependence, government initiatives, and organizational support. However obstacles like trouble getting treatment and problems with behavioral therapies that can cause relapse impede market expansion. The financing and initiatives of the government are essential in promoting treatments for opioid use disorder. Orexo AB is investigating Modia, a digital therapy for individuals with opioid use disorder (OUD), in collaboration with ApexB.io and Magellan Rx Management. Modia offers individualized psychotherapy sessions via mobile apps or PCs. In the meantime, Indivior PLC has successfully acquired Opiant Pharmaceuticals, Inc., expanding its therapeutic offerings for addiction, which now include the experimental opioid overdose therapy candidate OPNT003.
Key Market Insights:
Buprenorphine-based medications account for approximately 55% of the opioid use disorder treatment market share, driven by their effectiveness in managing withdrawal symptoms and reducing cravings with a lower risk of abuse compared to full opioid agonists.
Outpatient treatment programs constitute around 65% of the market demand for opioid use disorder services, reflecting the shift towards community-based care models and the need for long-term management of the condition.
In terms of region, North America holds the largest market share of about 45% for opioid use disorder treatments, attributed to the high prevalence of opioid addiction in the region and significant government initiatives to address the opioid crisis.
The adoption of digital therapeutics and telemedicine solutions for opioid use disorder management is growing at a rate of approximately 20% annually, driven by the need for improved access to treatment, especially in rural areas, and the increasing integration of technology in addiction care.
Global Opioid Use Disorder Market Drivers:
Increasing Acknowledgment of Buprenorphine Patches as an Effective Treatment Strategy to Promote Market Growth.
Patches for treating opioid addiction are becoming more and more popular because they are effective in treating opioid use disorder (OUD). These skin-applied patches have advantages like improved drug delivery and decreased discomfort. They are a useful choice for ongoing opioid therapy, especially for people who require medication continuously. As more patients enter the global market for the treatment of opioid use disorders, such collaborations are anticipated to accelerate the adoption of these therapies in the upcoming years.
Increasing the Number of Addictions to Opioids in Order to Gain Market Share.
Globally, there are serious health issues like cancer and heart disease, which are frequently managed with opioids and other painkillers. But if used for an extended period of time and stopped abruptly, these drugs can cause addiction and withdrawal symptoms. Globally, the prevalence of opioid addiction is increasing; according to the CDC, 2.7 million Americans who are 12 years of age or older will have an opioid use disorder in 2022. Serious consequences like opioid overdose deaths are more likely as a result of these trends.
Opioid Use Disorder Market Challenges and Restraints:
The adverse effects of drugs used in therapy present a barrier to the market for treatments for opioid addiction. These drugs may result in a range of physical symptoms, including cramping in the abdomen, joint pain, nausea, vomiting, diarrhea, constipation, respiratory problems, and muscle soreness. Strong drug reactions can also result in mental health problems like depression. The market is further impacted by alerts issued by regulatory agencies such as the U.S. FDA concerning dental problems associated with specific opioids, like oral buprenorphine dissolution. Even people who have never had dental problems before are susceptible to these conditions, which include cavities, tooth decay, oral infections, and tooth loss. The potential for market growth is constrained by these factors taken together.
Opioid Use Disorder Market Opportunities:
Increased participation from governmental and non-governmental organizations in spreading awareness about the risks of opioid overdose is another factor contributing to the growth of the market for opioid addiction treatment. Numerous organizations have increased their efforts to address and support individuals affected by opioid addiction as the number of cases of addiction is rising sharply. Prevention and treatment of drug abuse have received funding from many nations, including the United States through programs like Health and Human Services (HHS). These initiatives seek to prevent prescription drug abuse and improve access to medication-assisted therapy for treating opioid use disorders. These kinds of programs should encourage more people who are dealing with opioid-related problems to get treatment, which will help the global market in the years to come.
OPIOID USE DISORDER MARKET REPORT COVERAGE:
REPORT METRIC
DETAILS
Market Size Available
2023 - 2030
Base Year
2023
Forecast Period
2024 - 2030
CAGR
10.7%
Segments Covered
By Drug, Route of Administration, Age, Distribution Channel and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
Regional Scope
North America, Europe, APAC, Latin America, Middle East & Africa
Global Opioid Use Disorder Market Segmentation: By Drug
Buprenorphine
Sublocade
Belbuca
Suboxone
Zubsolv
Methadone
Naltrexone
Based on drug class, the market for opioid addiction treatment is divided into three segments: methadone, buprenorphine, and naltrexone. In 2022, buprenorphine is expected to hold a 36% share, leading the market. SUBLOCADE, SUBOXONE, and ZUBSOLV are just a few of the many branded drugs that are widely used in developed nations like the United States and France, contributing to their dominance. Despite an increase in generic options, the methadone market is predicted to grow at a slower rate of 23% as a result of fewer new product launches. The limited range of products that are expected to be available during the forecast period is the main reason why the naltrexone segment has a smaller market share.
Global Opioid Use Disorder Market Segmentation: By Route of Administration
Intravenous
Oral
Parenteral (injection-based) and oral routes of administration make up the two main segments of the market for opioid use disorder (OUD) treatment. With a projected market share of 53%, the parenteral segment is anticipated to continue holding the top spot throughout the forecast period. The availability of numerous injectable OUD medications in a range of dosages is what propels this dominance. The preference of many patients for oral medication delivery over injections is expected to cause the oral segment's global market share to grow significantly even though it is predicted to decline.
Global Opioid Use Disorder Market Segmentation: By Age
19 to 40
41 to 60
61 & over
The age groups that make up the market for treatment for opioid use disorders are 19 to 40, 41 to 60, and 61 and older. Due to changing lifestyles and a rise in the use of opioids for pain relief among younger and middle-aged people, the 19 to 40 age group dominated the market in 2022. With a projected market share of 42%, this segment is anticipated to maintain its leadership position in the market throughout the projection period.
Global Opioid Use Disorder Market Segmentation: By Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Stores
Online Pharmacies
Based on distribution channels, the market for drugs for opioid use disorders is divided into hospital pharmacies, retail pharmacies & stores, and online pharmacies. Because patients rely on hospital pharmacies for parenteral medications like buprenorphine, these establishments are predicted to hold a 39% market share. Due to patient preference for filling prescriptions at these locations, retail pharmacies and stores are anticipated to be the second-largest segment. As more people choose the convenience of online platforms to get their medications, internet pharmacies are predicted to grow at the fastest compound annual growth rate (CAGR).
Global Opioid Use Disorder Market Segmentation: By Region
North America
Europe
Asia-Pacific
South America
Middle East and Africa
With a predicted share of 45% during the forecast period, North America is anticipated to lead the global market for opioid use disorders. The prevalence of major market players, the large number of Americans impacted by opioid dependence, and the growing number of government initiatives aimed at halting the epidemic are the driving forces behind this leadership. For instance, the National Center for Biotechnology Information (NCBI) stated in 2020 that the number of Americans with opioid use disorder exceeded 2.1 million. Because of the increasing number of patients suffering from opioid dependence and the regular release of new products, Europe's market size is expected to trail that of North America. Due to rising healthcare costs and increased public awareness of the disease, the Asia Pacific region is predicted to grow at the fastest compound annual growth rate (CAGR) during the forecast period. It is also anticipated that markets in other formerly underrepresented regions—South America, the Middle East, and Africa—will grow. The number of patients suffering from opioid dependence will rise, along with healthcare spending and public awareness of opioid use disorder.
COVID-19 Impact on the Global Opioid Use Disorder Market:
The market for opioid use disorder (OUD) has been complicatedly impacted by the COVID-19 pandemic. The pandemic initially caused strain on the world healthcare system, which resulted in the 2020 postponement of elective procedures. As a result, there was less need for opioids to manage pain, which may have decreased the incidence of OUD. But during the pandemic, unforeseen events like postponed doctor's appointments led to a rise in long-term opioid use, which exacerbated cases of OUD. Opioid overdose has emerged as a major cause of injury-related mortality in the United States; the CDC predicts that by 2020, 2.7 million individuals will have experienced an OUD. Due to this combination, the market for OUD treatments was maintained even though there was a slight increase in the number of new opioid users as long as current users continued taking their medications as prescribed.
Latest Trend/Development:
Expanded access initiatives and technological advancements in digital health have been notable trends in the opioid use disorder (OUD) market. Remote addiction management is becoming more popular thanks to digital therapies like Probuphine implants and mobile app-based treatments. Efforts by the government to increase accessibility and affordability, like financing schemes for medication-assisted therapies like buprenorphine, are also becoming more prevalent. These changes are a reflection of the increased focus on cutting-edge therapies and larger support networks to tackle the problems associated with opioid addiction on a global scale.
Key Players:
Alkermes
Indivior PLC
BioDelivery Sciences International
Orexo US
Titan Pharmaceuticals
Omeros Corporation
Camurus
Hikma Pharmaceuticals PLC
AstraZeneca plc
Viatris Inc
Market News:
Titan Pharmaceuticals, Inc. and Indegene joined forces in June 2022 to improve their multichannel digital marketing strategy nationwide and increase the number of people with opioid addiction who can receive Probuphine implants.
The Buprenorphine Assistance Pilot Program was initiated in April 2023 by the New York State Office of Addiction Services and Supports (OASAS) and the New York State Department of Health (DOH). Through this program, the cost of buprenorphine for treating opioid use disorder (OUD) will be lessened in New York State, improving accessibility to this essential drug.
To Learn more about this report,
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Key Market Insights:
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
Global Automotive Lighting Market Drivers:
Using cutting-edge technology to illuminate the road, safety serves as a guiding light.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Beyond Performance-Based Luxuries Redefined by Light.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
Fuel Efficiency Takes the Lead: Illuminating Sustainability
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
To Learn more about this report,
Global Automotive Lighting Market Restraints and Challenges:
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
Global Automotive Lighting Market Opportunities:
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
AUTOMOTIVE LIGHTING MARKET REPORT COVERAGE:
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Application
Exterior Lighting
Interior Lighting
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
Global Automotive Lighting Market Segmentation: By Technology
Halogen
LED (Light-Emitting Diode)
Xenon
Emerging Technologies
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Global Automotive Lighting Market Segmentation: By Vehicle Type
Passenger Cars
Commercial Vehicles
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Global Automotive Lighting Market Segmentation: By Sales Channel
OEM (Original Equipment Manufacturers)
Aftermarket
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Region
North America
Asia-Pacific
Europe
South America
Middle East and Africa
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
COVID-19 Impact Analysis on the Global Automotive Lighting Market:
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
Recent Trends and Developments in the Global Automotive Lighting Market:
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Key Players:
AMS Osram
Cree
Hella
Hyundai Mobis
Koito
Luminus Devices
Magneti Marelli
Osram Licht AG
Stanley Electric
Valeo
Chapter 1. Opioid Use Disorder Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources Chapter 2. Opioid Use Disorder Market – Executive Summary
2.1 Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis Chapter 3. Opioid Use Disorder Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis Chapter 4. Opioid Use Disorder Market Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes Chapter 5. Opioid Use Disorder Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities Chapter 6. Opioid Use Disorder Market – By Drug
6.1 Introduction/Key Findings
6.2 Buprenorphine
6.3 Sublocade
6.4 Belbuca
6.5 Suboxone
6.6 Zubsolv
6.7 Methadone
6.8 Naltrexone
6.9 Y-O-Y Growth trend Analysis By Drug
6.10 Absolute $ Opportunity Analysis By Drug, 2024-2030 Chapter 7. Opioid Use Disorder Market – By Route of Administration
7.1 Introduction/Key Findings
7.2 Intravenous
7.3 Oral
7.4 Y-O-Y Growth trend Analysis By Route of Administration
7.5 Absolute $ Opportunity Analysis By Route of Administration, 2024-2030 Chapter 8. Opioid Use Disorder Market – By Age
8.1 Introduction/Key Findings
8.2 19 to 40
8.3 41 to 60
8.4 61 & over
8.5 Y-O-Y Growth trend Analysis By Age
8.6 Absolute $ Opportunity Analysis By Age, 2024-2030 Chapter 9. Opioid Use Disorder Market – By Distribution Channel
9.1 Introduction/Key Findings
9.2 Hospital Pharmacies
9.3 Retail Pharmacies & Stores
9.4 Online Pharmacies
9.5 Y-O-Y Growth trend Analysis By Distribution Channel
9.6 Absolute $ Opportunity Analysis By Distribution Channel, 2024-2030 Chapter 10. Opioid Use Disorder Market, By Geography – Market Size, Forecast, Trends & Insights
10.1 North America
10.1.1 By Country
10.1.1.1 U.S.A.
10.1.1.2 Canada
10.1.1.3 Mexico
10.1.2 By Drug
10.1.2.1 By Route of Administration
10.1.3 By Distribution Channel
10.1.4 Countries & Segments - Market Attractiveness Analysis
10.2 Europe
10.2.1 By Country
10.2.1.1 U.K
10.2.1.2 Germany
10.2.1.3 France
10.2.1.4 Italy
10.2.1.5 Spain
10.2.1.6 Rest of Europe
10.2.2 By Drug
10.2.3 By Route of Administration
10.2.4 By Distribution Channel
10.2.5 By Distribution Channel
10.2.6 Countries & Segments - Market Attractiveness Analysis
10.3 Asia Pacific
10.3.1 By Country
10.3.1.1 China
10.3.1.2 Japan
10.3.1.3 South Korea
10.3.1.4 India
10.3.1.5 Australia & New Zealand
10.3.1.6 Rest of Asia-Pacific
10.3.2 By Drug
10.3.3 By Route of Administration
10.3.4 By Distribution Channel
10.3.5 By Distribution Channel
10.3.6 Countries & Segments - Market Attractiveness Analysis
10.4 South America
10.4.1 By Country
10.4.1.1 Brazil
10.4.1.2 Argentina
10.4.1.3 Colombia
10.4.1.4 Chile
10.4.1.5 Rest of South America
10.4.2 By Drug
10.4.3 By Route of Administration
10.4.4 By Distribution Channel
10.4.5 By Distribution Channel
10.4.6 Countries & Segments - Market Attractiveness Analysis
10.5 Middle East & Africa
10.5.1 By Country
10.5.1.1 United Arab Emirates (UAE)
10.5.1.2 Saudi Arabia
10.5.1.3 Qatar
10.5.1.4 Israel
10.5.1.5 South Africa
10.5.1.6 Nigeria
10.5.1.7 Kenya
10.5.1.8 Egypt
10.5.1.9 Rest of MEA
10.5.2 By Drug
10.5.3 By Route of Administration
10.5.4 By Distribution Channel
10.5.5 By Distribution Channel
10.5.6 Countries & Segments - Market Attractiveness Analysis Chapter 11. Opioid Use Disorder Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
11.1 Alkermes
11.2 Indivior PLC
11.3 BioDelivery Sciences International
11.4 Orexo US
11.5 Titan Pharmaceuticals
11.6 Omeros Corporation
11.7 Camurus
11.8 Hikma Pharmaceuticals PLC
11.9 AstraZeneca plc
11.10 Viatris Inc
Fill out the form below and our team will get back to you shortly
FAQ's
The Global Opioid Use Disorder Market was valued at USD 3.21 billion and is projected to reach a market size of USD 6.54 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 10.7%.
Growing Recognition of Buprenorphine Patches as a Successful Treatment Approach to Drive Market Expansion and Increasing Cases of Opioid Addiction to Increase Market Share are the factors driving the Global Opioid Use Disorder Market.
Adverse OUD Drug Effects to Limit Market Growth.
Methadone drug type is the fastest growing in the Global Opioid Use Disorder Market.
Asia-Pacific region is the fastest growing in the Global Opioid Use Disorder Market.
More related reports
Get expert-driven market research reports from a leading research partner to help you navigate the future of the global industry.
Report Code: VMR-19361 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Newborn Screening Market was valued at approximately USD 6.14 Billion. It is projected to grow at a CAGR of around 7.6% during the forecast period of 2026–2030, reaching an estimated USD 8.86 Billion by 2030...
Report Code: VMR-19360 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19359 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19358 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Clinical Microbiology Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41 Bi...
Report Code: VMR-19356 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Global Fertility Services & IVF Technology Market was valued at approximately USD 53 Billion and is projected to reach around USD 82.30 Billion by 2030, expanding at a CAGR of about 9.2% during 2026–2030.
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”